Argus
•
Apr 15, 2026
XNCR: What does Argus have to say about XNCR?
Summary
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Amgen Inc.
May 01, 2026
•
AMGN
Analyst Report: Merck & Co., Inc.
May 01, 2026
•
MRK
Analyst Report: Bristol-Myers Squibb Company
Apr 30, 2026
•
BMY
Analyst Report: AstraZeneca PLC
Apr 30, 2026
•
AZN
Analyst Report: Regeneron Pharmaceuticals, Inc.
Apr 30, 2026
•
REGN
